[Effects of the injection of staphylocoagulase in rabbits. Attempt to prevent the defibrination syndrome].
D000347:Afibrinogenemia / Q000139:chemically induced*; D000818:Animals; D000933:Antifibrinolytic Agents / Q000627:therapeutic use*; D003030:Coagulase / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006867:Hydrolases; D007275:Injections, Intravenous; D011817:Rabbits; D013299:Streptodornase and Streptokinase / Q000627:therapeutic use; D013917:Thrombin / Q000627:therapeutic use; D013927:Thrombosis / Q000139:chemically induced*; D014812:Vitamin K / Q000037:antagonists & inhibitors
D000933:Antifibrinolytic Agents; D003030:Coagulase; D014812:Vitamin K; D006493:Heparin; D006867:Hydrolases; D013299:Streptodornase and Streptokinase; D013917:Thrombin
Effets de l'injection de staphylococagulae chez le lapin. Essais de prévention du syndrome de défibrination.